These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15926079

  • 1. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
    Livingston PO, Hood C, Krug LM, Warren N, Kris MG, Brezicka T, Ragupathi G.
    Cancer Immunol Immunother; 2005 Oct; 54(10):1018-25. PubMed ID: 15926079
    [Abstract] [Full Text] [Related]

  • 2. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
    Krug LM, Ragupathi G, Hood C, Kris MG, Miller VA, Allen JR, Keding SJ, Danishefsky SJ, Gomez J, Tyson L, Pizzo B, Baez V, Livingston PO.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6094-100. PubMed ID: 15447995
    [Abstract] [Full Text] [Related]

  • 3. Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.
    Krug LM, Ragupathi G, Ng KK, Hood C, Jennings HJ, Guo Z, Kris MG, Miller V, Pizzo B, Tyson L, Baez V, Livingston PO.
    Clin Cancer Res; 2004 Feb 01; 10(3):916-23. PubMed ID: 14871967
    [Abstract] [Full Text] [Related]

  • 4. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells.
    Cappello S, Liu NX, Musselli C, Brezicka FT, Livingston PO, Ragupathi G.
    Cancer Immunol Immunother; 1999 Dec 01; 48(9):483-92. PubMed ID: 10602885
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Sone S.
    Jpn J Cancer Res; 1996 May 01; 87(5):497-504. PubMed ID: 8641987
    [Abstract] [Full Text] [Related]

  • 14. Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides.
    Zhang S, Helling F, Lloyd KO, Livingston PO.
    Cancer Immunol Immunother; 1995 Feb 01; 40(2):88-94. PubMed ID: 7882387
    [Abstract] [Full Text] [Related]

  • 15. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
    Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L, Reisfeld RA.
    Cancer Res; 1986 Oct 01; 46(10):5112-8. PubMed ID: 3019521
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
    Bellone S, Roque D, Cocco E, Gasparrini S, Bortolomai I, Buza N, Abu-Khalaf M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Br J Cancer; 2012 Apr 24; 106(9):1543-50. PubMed ID: 22531721
    [Abstract] [Full Text] [Related]

  • 17. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
    Juhl H, Helmig F, Baltzer K, Kalthoff H, Henne-Bruns D, Kremer B.
    J Surg Oncol; 1997 Mar 24; 64(3):222-30. PubMed ID: 9121154
    [Abstract] [Full Text] [Related]

  • 18. Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer.
    Brezicka FT, Olling S, Bergman B, Berggren H, Engström CP, Hammarström S, Holmgren J, Larsson S, Lindholm L.
    Tumour Biol; 1992 Mar 24; 13(5-6):308-15. PubMed ID: 1337798
    [Abstract] [Full Text] [Related]

  • 19. Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues.
    Watarai S, Kiura K, Shigeto R, Shibayama T, Kimura I, Yasuda T.
    J Biochem; 1994 Nov 24; 116(5):948-54. PubMed ID: 7896755
    [Abstract] [Full Text] [Related]

  • 20. A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer.
    Ponath P, Menezes D, Pan C, Chen B, Oyasu M, Strachan D, LeBlanc H, Sun H, Wang XT, Rangan VS, Deshpande S, Cristea S, Park KS, Sage J, Cardarelli PM.
    Clin Cancer Res; 2018 Oct 15; 24(20):5178-5189. PubMed ID: 30021910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.